When Weighing Treatment Options for Cancer, It’s Important to Get More Than One Opinion

Article

“The concept that people have sometimes is that they put doctors on a pedestal, which is fine,” Bud Green said. And they somehow think that all doctors are kind of the same, and they're all as good. And I think that they need to see that different specialties look at things from a different perspective.

Bud Green and his wife, Gloria, advise others facing skin cancer diagnoses about the importance of educating themselves and being prepared to ask their health care teams the necessary questions to ensure they’re receiving the right treatment.

Over the last four years, Bud has had several cases of basal cell carcinoma and advanced cutaneous squamous cell carcinoma — the two most common forms of skin cancer.

Each time, his dermatologist performed a Mohs procedure to remove any traces of the cancers. However, during his most recent incidence of skin cancer, Bud and Gloria learned that surgery would no longer be a viable option as the procedure would have needed to be too extensive to remove all traces of the disease.

“It was seven weeks (of radiation) total and I'm still in radiation on my right cheek, and it was three weeks on the smaller (cyst),” Bud said in an interview with CURE®.

About a week into his radiation treatment, his oncologists realized that his disease was outrunning the radiation. After multiple consultations, Bud’s team decided to continue radiation and started him on the PD-1 inhibitor Libtayo (cemiplimab-rwlc).

Throughout his cancer experiences, Bud said he has learned firsthand that patients cannot sit on the sidelines waiting for their turn, but rather, they should be aggressive because their disease could be moving quickly. He said he’s learned it’s important for people to advocate for their own treatment.

“It's important for them to realize that (their disease may) not (be) typical, (and) that they need to consult with other medical specialists,” he said. “A lot of people go to a dermatologist, and (think) they did this pretty well (and) stick with what the dermatologist is saying. I think in this case, they need to go to an oncologist, maybe go to an ENT, go to the different specialists and even a radiation oncologist.”

The more patients advocate for themselves, according to Bud and Gloria, the better informed they are to choose the right option for their treatment.

“I think that people don't know enough about immunotherapy,” Gloria Green said in an interview with CURE®.“And we've learned a lot about it. And there's still so much we don't know about it. So, I think education for the general public would be really helpful.”

Importance of Second Opinions

Gloria cited her husband’s case as a prime example of how there’s a lack of information available to the average person with limited medical knowledge.

“Mohs was offered to Bud again, and in his case, it wouldn’t have been the right direction to go, at least according to the rest of the doctors we were talking to,” she said.

Bud acknowledged that many patients may find it difficult to switch doctors, but he stressed why it’s important to get more than one opinion.

“The concept that people have sometimes is that they put doctors on a pedestal, which is fine,” he said. And they somehow think that all doctors are kind of the same, and they're all as good. And I think that they need to see that different specialties look at things from a different perspective. And it’s that different perspective that you want to get from them.”

Another difference between relying on one opinion versus other specialist opinions is a possible outcome, Gloria said.

“If you don't go get another opinion, you could die,” she said. “If you get another opinion, you still could die, but at least you know your options.”

For more news on cancer updates, research and education, don’t forget to subscribe to CURE®’s newsletters here.

Related Videos
For patients with cancer, the ongoing chemotherapy shortage may cause some anxiety as they wonder how they will receive their drugs. However, measuring drugs “down to the minutiae of the milligrams” helped patients receive the drugs they needed, said Alison Tray. Tray is an advanced oncology certified nurse practitioner and current vice president of ambulatory operations at Rutgers Cancer Institute in New Jersey.  If patients are concerned about getting their cancer drugs, Tray noted that having “an open conversation” between patients and providers is key.  “As a provider and a nurse myself, having that conversation, that reassurance and sharing the information is a two-way conversation,” she said. “So just knowing that we're taking care of you, we're going to make sure that you receive the care that you need is the key takeaway.” In June 2023, many patients were unable to receive certain chemotherapy drugs, such as carboplatin and cisplatin because of an ongoing shortage. By October 2023, experts saw an improvement, although the “ongoing crisis” remained.  READ MORE: Patients With Lung Cancer Face Unmet Needs During Drug Shortages “We’re really proud of the work that we could do and achieve that through a critical drug shortage,” Tray said. “None of our patients missed a dose of chemotherapy and we were able to provide that for them.” Tray sat down with CURE® during the 49th Annual Oncology Nursing Society Annual Congress to discuss the ongoing chemo shortage and how patients and care teams approached these challenges. Transcript: Particularly at Hartford HealthCare, when we established this infrastructure, our goal was to make sure that every patient would get the treatment that they need and require, utilizing the data that we have from ASCO guidelines to ensure that we're getting the optimal high-quality standard of care in a timely fashion that we didn't have to delay therapies. So, we were able to do that by going down to the minutiae of the milligrams on hand, particularly when we had a lot of critical drug shortages. So it was really creating that process to really ensure that every patient would get the treatment that they needed. For more news on cancer updates, research and education, don’t forget to subscribe to CURE®’s newsletters here.
Yuliya P.L Linhares, MD, an expert on CLL
Yuliya P.L Linhares, MD, and Josie Montegaard, MSN, AGPCNP-BC, experts on CLL
Image of a man with a beard.
Image of a man with gray facial hair and a navy blue suit with a light orange tie.
Image of a woman with black hair.
Related Content